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Aggregation and Toxicology of
Titanium Dioxide Nanoparticles
doi:10.1289/ehp.10915
In their study of inhalation exposure of tita-
nium dioxide particles, Grassian et al. (2007)
presented a transmission electron micro-
graph (TEM) (their Figure 2A) as an image
of “dispersed” TiO2 nanoparticles. Yet, the
TiO2 nanoparticles in this TEM do not
appear to be dispersed. There is clear evi-
dence of self-organization of the nano-
particles into distinct assemblages, separated
by relatively large regions devoid of any par-
ticle. This spatial pattern, very unlikely to
occur randomly, is even more apparent when
Grassian et al.’s TEM is contrast-enhanced,
sharpened, and thresholded (Figure 1A) to
eliminate the initial grainy background.
With this image, one can demonstrate quan-
titatively the extent of clustering by calculat-
ing the radial distribution function
(Torquato 2002), defined as the probability
of finding a nanoparticle, in any direction, at
various distances away from the center of a
given nanoparticle. We compared the values
obtained for this function with those associ-
ated with an image in which the same nano-
particles have been artificially dispersed (with
image processing software). In the dispersed
case (Figure 1B), the probability of finding a
black pixel drops precipitously when the dis-
tance exceeds the apparent radius of nano-
particles, and then stays close to zero
thereafter. In the “original” case (Grassian
et al.’s Figure 2A), there is also a drop, but
the radial distribution function never gets to
zero. It progressively increases again as the
radial distance increases. This quantitative
difference between the curves in Figure 1B
leads to the conclusion that the nanoparticles
in Figure 1A are clustered. 
However, this conclusion is intriguing
in itself. Indeed, before obtaining their
TEM, Grassian et al. (2007) suspended the
TiO2 nanoparticles in methanol and soni-
cated the suspension for an unspecified, but
presumably appreciable “period of time.”
Given this strongly dispersive treatment, it
is remarkable that aggregation still occurred
to the extent it did. This observation sug-
gests that the 2- to 5-nm size of the primary
TiO2 “nano”-particles may be somewhat
irrelevant to environmental and toxicologic
concerns because in nature, under condi-
tions far more conducive to aggregation
than those imposed by Grassian et al.
(2007), nanoparticles may never be found
alone, but are part of significantly larger-
sized aggregates. In a recent study, French
et al. (French RA, Jacobson AR, Kim B,
Isley SL, Penn RL, Baveye PC, unpublished
data) observed that in aqueous suspensions
under a range of environmentally relevant
conditions of pH and ionic strength, TiO2
nanoparticles form aggregates of several
hundred nanometers to several micrometers
in diameter within minutes. 
This aggregation may have toxicologic
implications. In any given system (e.g.,
aerosols), it is possible that even a slight
change in pH or ionic strength may cause
TiO2 nanoparticles to cluster differently, and
therefore to have very dissimilar biological
activity. In general, this might explain mixed
results found in the literature on the toxicity
of TiO2 nanoparticles to environmentally
relevant species. Until now, these inconclu-
sive results have been explained (Oberdörster
et al. 2005) by arguing that the high biologi-
cal activity of TiO2 nanoparticles, caused by
their large specific surface area, creates a high
potential for inflammatory, pro-oxidant, and
antioxidant activity. Yet, conflicting observa-
tions may perhaps be imputable instead to
compounding factors due to nanoparticle
aggregation, which so far has not been given
serious consideration.
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Titanium Dioxide
Nanoparticles: Grassian et al.
Respond
doi:10.1289/ehp.10915R
Baveye and Laba have further analyzed the
transmission electron micrograph (TEM)
image shown in Figure 2A of our article
(Grassian et al. (2007b) to quantitatively
determine the extent of titanium dioxide
nanoparticle clustering in the image by cal-
culating the radial distribution function. The
main point of doing this calculation was to
demonstrate that TiO2 nanoparticle aggre-
gates will not completely deaggregate even
when subjected to harsh conditions.
We completely agree with the statement
of Baveye and Laba that “aggregation may
have toxicologic implications.” We disagree
with their suggestion that “nanoparticle
aggregation … so far has not been given
serious consideration.” There is growing
consensus that nanoparticle aggregation is
an important factor in understanding the
health implications of nanoparticles. This
has been described by researchers working in
the area of nanoparticle toxicity (Balbus
et al. 2007; Powers et al. 2006), as well as by
us. In addition to Grassian et al. (2007b),
we refer to another study in which we fur-
ther investigated TiO2 nanoparticle aggrega-
tion in inhalation and instillation studies
(Grassian et al. 2007a). In that study we
demonstrated that the size and nature of
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Figure 1. (A) Contrast-enhanced, sharpened, and
segmented version of a TEM of a TiO2 nanoparti-
cle suspension (modified from Grassian et al.
2007). (B) Radial distribution function versus radial
distance for a representative point in a nanoparti-
cle in (A); the dashed line indicates values for the
“original image” [Figure 2A from Grassian et al.
(2007)] and the solid line represents a similar point
in an image where the nanoparticles are artifi-
cially dispersed.
1.0
0.8
0.6
0.4
0.2
0
01234567
Radial length (nm)
R
a
d
i
a
l
 
d
i
s
t
r
i
b
u
t
i
o
n
 
f
u
n
c
t
i
o
n
Dispersed
Original image
A
B
Perspectives | Correspondencenanoparticle aggregates are important factors
in evaluating their toxicity, and we sug-
gested that the natural behavior of these par-
ticles and the manner in which people are
exposed are critical factors in determining
risk. If the nanoparticles do not deaggregate
when inhaled, then the aggregation size and
nature may be significant physicochemical
properties in the toxicity of nanoparticles.
Moreover, combining extensive physico-
chemical characterization studies of nano-
particles with evaluation of their toxicity, as
we have done (Grassian et al. (2007a,
2007b), will foster greater understanding of
the environmental health impacts of nano-
technology. 
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DDT and Breast Cancer
doi:10.1289/ehp.11025
In a recent article, Cohn et al. (2007) noted
an association between increased breast can-
cer risk and p,p´-DDT [1,1,1-trichloro-2,2-
bis(p-chlorophenyl)ethane] exposure early in
life. Their article should be interpreted with
caution, particularly the estimated 5-fold
increase in risk for women born after 1931
the authors reported without qualification in
the “Abstract”; this value was repeated in the
news article by Manuel (2007). Cohn et al.
(2007) evaluated three DDT congeners—that
is, p,p´-DDT, o,p´-DDT [1,1,1-trichloro-2(p-
chlorophenyl)-2-(o-chlorophenyl)ethane], and
p,p´-DDE [1,1-dichloro-2,2-bis(p-chloro-
phenyl)ethylene]—by various categories of
year of birth, yet they found no significantly
increased risk estimates for any of the three
DDT congeners in multiple comparisons
that were not adjusted for the other DDT-
related chemicals either in all women or in
women born after 1931. The estimated
5-fold increase in risk for the upper tertile of
p,p´-DDT serum levels was only observed in
subgroup analyses that were both restricted
to women born after 1931 and adjusted for
serum level of o,p´-DDT. The impact of the
adjustment for o,p´-DDT on the risk esti-
mate for p,p´-DDT is remarkable in view of
the low o,p´-DDT levels observed (35%
were below the limit of detection). A signifi-
cant inverse association between o,p´-DDT
level and breast cancer risk, which was inter-
preted by Cohn et al. in terms of length of
time since DDT exposure, became stronger
after adjustment for p,p´-DDT levels; pre-
sumably this does not indicate a protective
effect of recent DDT exposure.
In view of the absence of evidence for an
association between p,p´-DDE levels and
breast cancer risk (Lopez-Cervantes et al.
2004), it seems unlikely that DDT exposure
increases the risk of breast cancer.
Nonetheless, if the effect of DDT exposure
early in life on breast cancer risk is large [a
possibility suggested by Cohn et al. (2007)],
then the decreasing birth cohort trend in
breast cancer risk that has been observed for
U.S. baby boomers is even more remarkable
(Chu et al. 1999; Tarone 2006, 2007;
Tarone and Chu 2000). Women born after
1945 would have been exposed to DDT for
each of the first 13 years of life, with increas-
ing exposure through the late 1960s (Wolff
et al. 2005), but the birth cohort risk of
breast cancer showed a marked decrease
among U.S. women for over two decades
after 1945. DDT exposure would join a list
of other breast cancer risk factors predicting
increasing breast cancer risk in baby boomers
(Tarone 2006); yet the birth cohort risk of
breast cancer decreased for women born after
1945. That the hypothesized association
between DDT exposure and breast cancer
risk has received far more attention than the
paradoxical decreasing risk of breast cancer
that has actually occurred among young U.S.
women says much about the priorities and
focus of environmental epidemiology.
The author declares he has no competing
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et al. Respond
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We thank Tarone for his letter, as it pro-
vides an opportunity to elaborate on analytic
strategies for the study of DDT associations
with breast cancer. 
One feature of our study (Cohn et al.
2007)—assessment of exposure in blood
samples collected during active DDT use in
the 1960s—provided a unique opportunity
to examine three DDT-related compounds
singly and in combination. The three DDT-
related compounds studied represent distinct
aspects of exposure. p,p´-DDT [1,1,1-
trichloro-2,2-bis(p-chlorophenyl)ethane] is
the primary ingredient of commercial grade
DDT. p,p´-DDE [1,1-dichloro-2,2-bis(p-
chlorophenyl)ethylene], the most persistent
DDT-related compound, is a metabolite of
p,p´-DDT that is both made by humans
during active exposure, and also ingested
directly from food sources where it can be
stored for long periods in fat (Morgan and
Roan 1975). o,p´-DDT [[1,1,1-trichloro-2(p-
chlorophenyl)-2-(o-chlorophenyl)ethane] is a
low-concentration contaminant of commer-
cial DDT that is eliminated by humans most
quickly, making it a marker of recent expo-
sure (Morgan and Roan 1975). Therefore,
absolute and relative DDT/DDE isomer lev-
els may represent different windows of expo-
sure (Wolff et al. 2007).
Unlike our investigation, most other
breast cancer studies were conducted long
after active use of DDT ceased. Thus the pre-
ponderance (> 95%) of their exposure was
only p,p´-DDE [see our Figure 1 and Table 1
(Cohn et al. 2007)]. Hence, our study
provides new information. An additional
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Correspondencedimension is that these compounds have
been shown to have distinctly different
endocrine activity (Kelce et al. 1995), sug-
gesting potential for differential effects on
human outcomes. Therefore, we disagree
with Tarone’s assertion that the lack of an
association between p,p´-DDE and breast
cancer risk in young women refutes a role
for p,p´-DDT exposure. The timing, origin,
and functional activity may differ for each
compound.
Concurrent measurements of p,p´-DDT,
p,p´-DDE, and o,p´-DDT allow evaluation
of potential differences in the effects of these
compounds. Other studies have also
observed differing associations with cancer
risk for p,p´-DDT and its metabolite,
p,p´-DDE. McGlynn et al. (2006) reported
that the p,p´-DDT association with risk of
liver cancer was enhanced when p,p´-DDE
was low. We also reported that a higher pro-
portion of p,p´-DDT to p,p´-DDE in
maternal serum samples was associated with
longer time to pregnancy in their daughters
30 years after exposure in utero (Cohn et al.
2003). In another other breast cancer study,
Romieu et al. (2000) showed a significant
effect for p,p´-DDE—after adjustment for
p,p´-DDT—for predicting breast cancer,
particularly in postmenopausal women. We
believe that simultaneous adjustment for
DDT-related compounds is a strength of
our study.
Tarone suggests that subgroup analyses
weaken the results of our article (Cohn
et al. 2007). However, we pointed out in
our article that subgroup analyses, by birth
cohort, were planned a priori and were a
primary objective of our study. In this set-
ting, subgroup analyses are a strength that
enabled us to examine whether age at DDT
exposure may be of importance in human
breast cancer.
The trends in breast cancer incidence in
young women previously presented by
Tarone in Table 1 of his article (Tarone
2006) do not refute a possible effect of
DDT exposure in childhood. Successive
birth cohorts of women diagnosed at
20–39 years of age between 1975 and 2002
(Table 1; Tarone 2006) experienced
decreasing DDT exposure in childhood
(birth years 1941–1982) because DDT use
began in 1945, peaked in 1959, and was
banned in 1972 in the United States (U.S.
Environmental Protection Agency 1975).
Successive birth cohorts of women diag-
nosed at 40–49 years of age between 1990
and 2002 (Table 1 in Tarone 2006) were
all exposed to DDT in childhood (birth
years 1941–1962); therefore, breast cancer
trends for these birth cohorts are not infor-
mative for investigating effects of DDT
exposure in childhood. Further, we agree
with Weiss (2007) that trends in invasive
disease and mortality cannot be interpreted
without consideration of the rising inci-
dence of in situ disease and its successful
treatment, which would reduce incidence of
invasive disease and mortality.
The authors declare they have no competing
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Comments on “The Sweet
Scent on Baby’s Breath?”
doi:10.1289/ehp.10993
The stated mission of Environmental Health
Perspectives (EHP) is
to serve as a forum for the discussion of the inter-
relationships between the environment and
human health by publishing in a balanced and
objective manner the best peer-reviewed research
and most current and credible news of the field.
(EHP 2008)
We would like to focus on the part of
your mission statement, regarding “a balanced
and objective manner.” For the third time in
about as many years, we find ourselves writ-
ing to EHP to correct inaccuracies in its
reporting of the state of the science regard-
ing fragrance ingredients and our under-
standing of their fate and effects in the
environment and human health. 
Your news item “The Sweet Scent on
Baby’s Breath?” (Potera 2007) is yet another
example of information conveyed by your
journal in a manner that is neither balanced
nor objective. For example, you quote the
work of Luckenbach and Epel (2005), yet
omit the clarifications from the Research
Institute for Fragrance Materials (RIFM)
that EHP published in a follow-up letter to
the editor (Salvito 2005). 
You continue to allow reiteration of the
inaccurate statement that there is little
known about the polycyclic musks, when in
fact a robust body of scientific studies pub-
lished in a number of peer-reviewed journals
are in fact available, and have been used to
support a thorough evaluation in Europe of
the risks of these ingredients to human
health and environment. 
6-Acetyl-1,1,2,4,47-hexamethyltetraline
(AHTN) and hexahydro-hexamethyl-
cyclopenta (γ)-2-benzopyran (HHCB) have
been assessed by the Scientific Committee
on Cosmetic and Non-Food Products
(SCCNFP 2002a, 2002b) of the European
Union and were determined to be safe to
human health for their use in cosmetic
products. This was noted by Salvito (2005)
in his response to the work of Luckenbach
and Epel (2005). These ingredients have
also been evaluated by the European
Chemicals Bureau (ECB) for determination
of their environmental hazards [persistence,
bioaccumulation, and toxicity (PBT)], and
the ECB has determined that these materials
are not PBTs (European Chemical Bureau
2004). In addition, the SCCNFP issued
favorable opinions on both AHTN and
HHCB, finding them safe for use in cos-
metic products (SCCNFP 2002a, 2002b).
Further, there have been > 40 publications in
peer-reviewed scientific journals pertaining
to the human health and environmental
safety of polycyclic musks (references avail-
able upon request).
As a peer-reviewed journal whose stated
mission is to present the best science in an
objective manner, we are disappointed with
your continued lack of objectivity and
inability to collect the necessary information
to present a true perspective of the science.
It would appear that your news staff needs
to perform more thorough research in
preparing their reports and that your peer-
review process may be incomplete. 
The RIFM, a nonprofit organization
whose research is governed by an independent
A 154 VOLUME 116 | NUMBER 4 | April 2008 • Environmental Health Perspectives
Correspondenceexpert panel, was established to provide the
research and testing necessary to assure the
safety of ingredients used in the creation of
fragrances. The RIFM has been in existence
for > 40 years and has well-established
relationships with academia; it is also well
known among many regulatory agencies
around the world for publishing its work in
the peer-reviewed literature. Our organiza-
tion, as well as others from our industry, are
listed on the U.S. Environmental Protection
Agency’s website under related links
(U.S. EPA 2007).
The authors are employed by the Research
Institute for Fragrance Materials, which pub-
lishes its work in the peer-reviewed literature
under the guidance of an independent scientific
panel and receives support from the private sector.
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Editor’s note: Forum articles are short and
cannot be all-inclusive of a topic. “The Sweet
Scent on Baby’s Breath?”[Environ Health
Perspect 115:A491 (2007)] focused on the pres-
ence of polycyclic musks in breast milk in the
United States, which had never been measured
before the study by Kannan and colleagues
[Environ Sci Technol 41(11):3815–3820
(2007)]. That said, Smith and Salvito are cor-
rect that comment from an industry source
should have been included in this article. 
Both researchers interviewed for this article
[Environ Health Perspect 115:A491 (2007)]
expressed concern about the impact of long-term
bioaccumulation of polycyclic musks, as well as
the lack of full understanding thereof. This
concern is shared by others in the field; for
example, the most recent Lake Michigan
Lakewide Management Plan (http://www.
epa.gov/lakemich/2006/index.html) includes
six polycyclic musks—including AHTN and
HHCB—on a watch list of pollutants to be
reviewed in 2008. As researchers look at differ-
ent end points (such as efflux transporters) or
sentinel species (such as mussels), new data will
continue to emerge that warrant further inves-
tigation, as well as reporting.
The Interaction of Agricultural
Pesticides and Marginal Iodine
Nutrition Status as a Cause of
Autism Spectrum Disorders
doi:10.1289/ehp.11010
Roberts et al. (2007) recently reported on the
results of their investigation into the relation-
ship between agricultural pesticides and
autism spectrum disorders (ASD) and found
an association between organochlorines and
ASD. One possible mechanism for this rela-
tionship is through thyroid disruption
(Cheek et al. 1999). There is evidence to sug-
gest that iodine deficiency might be associ-
ated with some of the increase in the reported
prevalence/incidence of autism (Sullivan and
Maberly 2004). For pregnant women who
have a marginal iodine nutrition status, the
disruption of the thyroid due to exposure to
organochlorines could induce iodine defi-
ciency and result in negative effects on the
brain of the developing fetus. The U.S.
iodine nutrition status has declined markedly
over the last three decades, with the current
iodine nutrition status among pregnant
women being marginal (Caldwell et al. 2005;
Hollowell et al. 1998). Because of the current
iodine status of pregnant women, the Public
Health Committee of the American Thyroid
Association (2006) has recently recom-
mended that all pregnant and lactating
women take daily iodine supplements. It is
interesting that the ASD case mothers tended
to be older and more likely to be non-
Hispanic white and non-Hispanic black than
controls, which is consistent with a poorer
iodine nutrition status in older women and in
non-Hispanics in the United States (Caldwell
et al. 2005; Hollowell et al. 1998).
Ensuring adequate iodine nutrition
status of women, especially throughout
pregnancy, is an extremely important public
health goal. Given the negative effects of a
number of environmental chemicals on the
thyroid (Zoeller and Crofton 2000), it
becomes increasingly important to ensure
that all women have an adequate iodine
intake and that the recommended approach
to assuring adequate iodine nutrition is
through a comprehensive iodized salt pro-
gram (International Council for Control of
Iodine Deficiency Disorders/United
Nations Children’s Fund /World Health
Organization 2001; Sullivan 2007).
The author is a board member of the
International Council for the Control of Iodine
Deficiency Disorders.
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